Dublin, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The "Lysosomal Storage Disease Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
Gain Therapeutics, a preclinical biotech developing small molecule therapies for lysosomal storage disorders, announced terms for its IPO on Wednesday. The Bethesda, MD-based company plans to raise ...
Spruce Biosciences, Inc. (SPRB) on Monday said that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to tralesinidase alfa enzyme replacement therapy (TA-ERT) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback